Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pattern Genomics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Pattern Genomics

Pattern Genomics

Seed

Pattern Genomics: Advanced bioinformatics platform for efficient diagnostic assay design and infectious disease profiling.

HQ
Madison, CT, US
Founded
2012
Overview
Compare
Fundraising
Employees

Pattern Genomics, founded in 2011, focuses on developing advanced bioinformatics solutions for diagnostic assay design and infectious disease profiling. Their core product, Daydreamerâ„¢, leverages next-generation sequencing to identify subtype differences in large sequence collections, enabling efficient, data-driven diagnostic processes.

Pattern Genomics has significantly impacted the bioinformatics field by streamlining diagnostic assay design, enhancing the accuracy and speed of infectious disease detection. Their innovative approach has positioned them as a key player in the biotechnology sector.

Pattern Genomics - Similar Companies

Pattern Bioscience logo

Pattern Bioscience

pattern.bio

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Pointcare Genomics logo

Pointcare Genomics

Genomenon logo

Genomenon

genomenon.com

Sequegenics logo

Sequegenics

sequegenics.com

Paradise Genomics logo

Paradise Genomics

Inform Genomics logo

Inform Genomics

informgenomics.com

GenomeNext logo

GenomeNext

ID Genomics logo

ID Genomics

idgenomics.com

Navipoint Genomics logo

Navipoint Genomics

Day Zero Diagnostics logo

Day Zero Diagnostics

Lightspeed Genomics logo

Lightspeed Genomics

Aperiomics logo

Aperiomics

Streamline Genomics logo

Streamline Genomics

Accelevir Diagnostics logo

Accelevir Diagnostics

Pattern Genomics - Quick Facts

Who are Pattern Genomics' competitors?

Companies similar to Pattern Genomics include Pattern Bioscience, Bioinfoexperts, Pointcare Genomics and Genomenon.

When was Pattern Genomics founded?

Pattern Genomics was founded in 2012.

Where is Pattern Genomics' headquarters located?

Pattern Genomics' headquarters is located in Madison, CT, US.

When was Pattern Genomics' last funding round?

Pattern Genomics' most recent funding round was for $150k (USD) in March 2013.

How much has Pattern Genomics raised to-date?

As of Mar 21, 2013, Pattern Genomics has raised a total of $150k (USD).

How many employees does Pattern Genomics have?

Pattern Genomics has 2 employees as of Feb 4, 2024.

Pattern Genomics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Bioinformatics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Assays
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software